SCHEMBL189244

SCHEMBL189244

Nc1nc2cccc(-c3cccnc3)c2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASH1L Q9NR48 1/20 0.59
PIK3CD O00329 1/20 0.54
PIP5K1C O60331 1/20 0.54
PIK3CA P42336 1/20 0.54
PI4KA P42356 1/20 0.54
PI4KB Q9UBF8 1/20 0.54
TGFBR1 P36897 1/20 0.48
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP2A6 P11509 6/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2E1 P05181 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2B6 P20813 2/20 0.45
CYP2C19 P33261 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TDO2 P48775 1/20 0.43
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27945402 0.83 NPC1 (0.45) ASH1LCYP2A6CYP3A4CYP2E1CYP2D6
SCHEMBL14860945 0.82 ASH1L (0.62) ASH1LPIK3CDPIK3CAPI4KAPI4KB
SCHEMBL31621268 0.82 ASH1L (0.62) ASH1LPIK3CDPIK3CAPI4KAPI4KB
SCHEMBL189243 0.76 PIK3CD (0.54) PIK3CDPIP5K1CPIK3CAPI4KAPI4KB
SCHEMBL18202841 0.75 ASH1L (0.51) ASH1LALDH1A1MAPT
SCHEMBL19608483 0.74 ASH1L (1.00) ASH1LPIK3CDPIK3CAPI4KAPI4KB
SCHEMBL30311987 0.74 ASH1L (0.54) ASH1LPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL29013231 0.74 ASH1L (0.54) ASH1LPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL34471238 0.72 FTO (0.54) ASH1LPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL2760411 0.72 PIK3CD (0.57) PIK3CDPIP5K1CPIK3CAPI4KAPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401273-A1 TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2012-01-04 EP disclosed